Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
WillScot Holdings Corporation has elected Donald Slager, former CEO of Republic Services, to its Board of Directors as an independent director. Slager brings extensive experience in corporate governance and leadership during transformative periods, expected to support WillScot's long-term strategic objectives. He joins key committees to aid governa…
Jasper Therapeutics announced an offer to purchase all outstanding warrants issued during its 2025 public offering, aiming to reduce potential dilution of its common stock. The company will pay $0.324 per warrant in cash to buy back up to approximately 12.3 million warrants, representing a $4 million cash outlay. The offer is open until November 6,…
Virtu Financial, a global multi-asset financial services provider, will release its third quarter 2026 earnings on November 5, 2026, before the US market opens. The company will hold a conference call and webcast to discuss the results, focusing on its global liquidity and trading solutions across various asset classes.
Pacira BioSciences and the Caregiver Action Network conducted a national survey revealing that family caregivers often feel unprepared to manage postsurgical pain and recovery at home. The survey highlights gaps in communication about pain management options, especially non-opioid therapies, and underscores caregivers’ need for clearer, practical i…
Akebia Therapeutics announced that key executives will participate in one-on-one meetings at the virtual U.S. Bancorp I BTIG Kidney Health Forum, discussing their commercial products and clinical pipeline focused on rare kidney diseases.
Roundtable (NASDAQ: RTB), an AI and DeFi-powered Enterprise Media Operating System, announced Erin Schaefer, former senior executive at Google, YouTube, and Niantic Games, has joined its Board of Directors. Schaefer brings extensive experience in scaling multi-billion-dollar commercial media businesses and strategic leadership in technology and bra…
Kyverna Therapeutics announced presentation of encouraging one-year data from its pivotal Phase 2 trial of miv-cel, a CD19 CAR T-cell therapy, in stiff person syndrome (SPS), showing sustained clinical benefit and a favorable safety profile. Additionally, updated positive Phase 1 data in progressive multiple sclerosis (MS) will be shared. These res…
Texas Capital Bancshares, Inc. will release its third quarter 2026 financial results after market close on October 21, 2026, followed by a conference call and webcast hosted by executive management to discuss operating results. The company provides comprehensive financial services in commercial, consumer, corporate and investment banking, with mult…
Sunrun Inc., America's leading home solar and battery storage provider, announced its third quarter 2026 earnings release date set for November 4, 2026, followed by an investor conference call to discuss the results.
Mobilicom Limited announced its participation at AUSA 2026 where it will showcase a new cybersecure communication solution designed for autonomous defense operations, addressing increasing data demands. Additionally, the company will present its business and growth opportunities in the drone, robotics, and defense sectors at the ThinkEquity investo…
Ironwood is a small-cap biotech trading at bargain multiples backed by solid LINZESS economics and meaningful free cash flow. The stock is fundamentally a call on the company executing and advancing a second Phase 3 apraglutide trial requested by regulators. If the company proves the program is on track, the re-rating can be substantial; failure or…
OR Royalties reported Q3 deliveries of 20,237 GEOs and $90.2M of revenue with a cash margin of 96.8%, left $76.7M of cash on the balance sheet, and still has significant available lending capacity. The stock trades at $34.47, well below a 52-week high of $48.06; we see tactical upside to $40.00 on continued GEO delivery growth, accretive small acqu…
dLocal's rapid TPV growth and exceptional net retention argue that recent margin compression is the byproduct of scaling into large enterprise flows and competitive pricing, not a permanent structural decline. At a $4.1B market cap and $14.53 stock price, the risk/reward favors a long, with a clear entry at $14.53, stop at $11.50 and a target of $2…
Nexentis Technologies has announced that its subsidiary MitoCareX Bio has deployed its computational drug discovery infrastructure on Google Cloud Platform, aiming to improve computational capacity, data governance, and operational flexibility. This strategic move is designed to support MitoCareX's evolving drug discovery programs by enabling scala…
West Pharmaceutical (WST) is a well-capitalized, cash-generative supplier of containment and delivery systems for injectables. Recent dynamics - stronger HVP uptake, biopharma exposure, and regulatory-driven Annex 1 upgrades - support continued revenue and margin improvement. Valuation is rich (P/E ~46, EV/EBITDA ~28.8) so this is a buy with measur…
Sportradar Group AG announced an agreement to sell Atrium Sports, the coaching and scouting segment of Synergy Sports, to Teamworks Innovations for $170 million in cash. This divestiture allows Sportradar to streamline its business and concentrate on its principal betting, gaming, and media operations while retaining key technology assets. The tran…
Hillman Solutions Corp., a leading hardware provider, will release its Q3 2026 earnings after market close on November 2, followed by a results presentation and conference call on November 3. The company will discuss its financial performance for the thirteen and thirty-nine weeks ended September 26, 2026.
Crane NXT, a global leader in authentication and traceability technologies, announced the appointment of Jeong H. Kim to its Board of Directors effective October 29, 2026. Dr. Kim brings extensive leadership experience in advanced technologies and commercializing innovations, expected to support Crane NXT's growth and market leadership.
Atlantic HPC Group Inc, a U.S.-based digital infrastructure company focused on bitcoin mining, announced the appointment of Leo Lin as its new CEO effective October 1, 2026. Lin brings over 20 years of executive experience, including leadership roles in tech and finance sectors. The company is planning to expand its operations from bitcoin mining t…
Beam Global has signed a definitive agreement to acquire Norway-based drone technology company ScoutDI for approximately $24 million. The acquisition aims to establish Beam as a vertically integrated U.S. drone manufacturer with capabilities in energy, mobility, and defense markets. ScoutDI's drone systems, including those with conditional U.S. Dep…
BrewDog, owned by Tilray Brands, is spearheading a UK-wide campaign called 'Choose Craft' to revitalize the craft beer market. The campaign celebrates quality ingredients, flavor, and the craft beer community, driving a 2.87x sales increase in key products. BrewDog also secured eight new on-trade partnerships, expanding its footprint in entertainme…
AvePoint is showing signs of durable cash generation and getting a direct demand lift from enterprises scrambling to govern AI. At a market cap just above $3.0B and free cash flow of $100.2M, the stock offers a mid-term trade with defined risk controls as sentiment and fundamentals drift higher.
FMAO looks cheap for a regional with $3.4B+ in assets, a $487M market cap, and improving profitability. Rising net interest margin (industry tailwinds plus local loan growth), a history of dividend increases and a conservative balance sheet create room for a re-rate to a mid-teens P/E. Entry at $35.40, target $42.00, stop $31.00 for a long-term (18…
Marvell's investor day on 10/06/2026 reset expectations: FY2028 revenue guidance was raised to $20B and management disclosed an aggressive multi-year plan toward $70-90B in sales by FY2031. The stock is extended but supported by real backlog and strategic partnerships. This trade idea lays out a mid-term swing: buy into momentum with a stop below s…
Caspian Therapeutics, formed from menin-inhibitor research at Kura Oncology, is advancing KO-7246, a novel oral menin inhibitor aimed at treating diabetes by restoring beta-cell function. Kura Oncology and Caspian will present preclinical data at an upcoming investor webcast, highlighting progress and potential applications of this therapy in cardi…
